The Telangana Drugs Control Administration (DCA) has issued an urgent Stop Use Notice for a pediatric formulation Almont-Kid Syrup (Batch No. AL-24002) after laboratory testing revealed contamination with Ethylene Glycol—a highly toxic industrial chemical that has no place in medicines, especially those meant for children.
Why this is extremely serious
Ethylene Glycol is known to cause acute kidney injury, metabolic acidosis, neurological toxicity, and even death, particularly in children. Even small quantities can be dangerous. Its presence in a pediatric allergy/asthma medication is a grave quality failure and a public health concern.
About the affected medicine
Drug composition: Levocetirizine Dihydrochloride + Montelukast Sodium
Common use: Allergic rhinitis, wheezing, asthma-related symptoms in children
Affected batch: AL-24002 only
Regulatory instructions
Immediate stop use of the affected batch
All pharmacies, hospitals, and clinics instructed to freeze and remove stock
Citizens and healthcare professionals asked to report possession of this batch to authorities
Helpline for reporting: 1800 599 6969
Why this matters to healthcare professionals
This incident is a reminder that drug safety doesn’t end at prescribing. Pharmacists, doctors, nurses, and caregivers play a crucial role in:
Verifying batch details during dispensing
Educating parents about medicine safety
Reporting suspected quality issues early
Staying alert to regulatory advisories
History has shown that excipient contamination can have devastating consequences if missed. Vigilance saves lives.
Call to action
Please share this alert with colleagues, parents, and caregivers. If you encounter this batch anywhere—report it immediately.
How often do we, as healthcare professionals, actively check drug safety alerts and batch recalls before dispensing or administering medicines?
Patient safety begins with awareness.
MBH/PS